Molecular immunology · 2026
The IL-27/IL-27R axis attenuates hypoxia-induced cardiac remodeling and is associated with altered p38 MAPK signaling.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Xue Guan-Zhen, Song Xiaoyan, Liu Yanmin, Tuo Yajun, Yin Zhinan, Wang Qian, Wuren Tana
Аннотация
BACKGROUND: Chronic hypoxia is a major driver of pulmonary hypertension (PH) and adverse cardiac remodeling. Although IL-27/interleukin-27 receptor (IL-27R) signaling has been implicated in tissue-protective responses, its role in hypoxia-induced cardiac remodeling remains unclear.
METHODS: We used a combination of in vivo and in vitro approaches to investigate the role of IL-27/IL-27R in hypoxia-induced cardiac remodeling. Wild-type (WT) and interleukin-27 receptor α knockout (IL-27Rα KO) mice were exposed to chronic hypoxia. Interventions included recombinant mouse IL-27 (rmIL-27), lipid nanoparticle-encapsulated IL-27 mRNA (LNP-IL-27 mRNA), and sildenafil. Echocardiographic, histological, and molecular analyses were performed to assess cardiac remodeling.
RESULTS: IL-27Rα deficiency was associated with worsened hypoxia-induced remodeling, including more marked cardiac structural abnormalities, impaired functional indices, and increased myocardial fibrosis. rmIL-27 attenuated these changes and showed more consistent protective effects than LNP-IL-27 mRNA and sildenafil across the measured endpoints. In hypoxic cardiomyocytes, IL-27 was associated with altered downstream signaling, with p38 MAPK showing a pattern more closely associated with the protective phenotype than STAT1 or STAT3.
CONCLUSION: The IL-27/IL-27R axis attenuates chronic hypoxia-induced cardiac remodeling, with associated changes in p38 MAPK signaling, although the underlying mechanisms require further investigation.
METHODS: We used a combination of in vivo and in vitro approaches to investigate the role of IL-27/IL-27R in hypoxia-induced cardiac remodeling. Wild-type (WT) and interleukin-27 receptor α knockout (IL-27Rα KO) mice were exposed to chronic hypoxia. Interventions included recombinant mouse IL-27 (rmIL-27), lipid nanoparticle-encapsulated IL-27 mRNA (LNP-IL-27 mRNA), and sildenafil. Echocardiographic, histological, and molecular analyses were performed to assess cardiac remodeling.
RESULTS: IL-27Rα deficiency was associated with worsened hypoxia-induced remodeling, including more marked cardiac structural abnormalities, impaired functional indices, and increased myocardial fibrosis. rmIL-27 attenuated these changes and showed more consistent protective effects than LNP-IL-27 mRNA and sildenafil across the measured endpoints. In hypoxic cardiomyocytes, IL-27 was associated with altered downstream signaling, with p38 MAPK showing a pattern more closely associated with the protective phenotype than STAT1 or STAT3.
CONCLUSION: The IL-27/IL-27R axis attenuates chronic hypoxia-induced cardiac remodeling, with associated changes in p38 MAPK signaling, although the underlying mechanisms require further investigation.